|
|
|
|
|
|
|
Bioscrip Inc (BIOS)
|
|
0 (0%)
|
|
|
Open:
|
|
Pre. Close:
|
|
|
High:
|
|
Low:
|
|
|
Volume:
|
|
Market Cap:
|
0M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
2.704 - 2.723
|
2.723 - 2.737
|
|
Low:
|
2.581 - 2.606
|
2.606 - 2.626
|
|
Close:
|
2.615 - 2.649
|
2.649 - 2.676
|
|
|
|
Technical analysis (as of: 2018-04-25 1:48:48 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 3.28 One year: 3.83
|
|
Support:
|
Support1: 2.50 Support2: 2.31
|
|
Resistance:
|
Resistance1:
2.81 Resistance2: 3.28
|
|
Pivot:
|
2.63
|
|
Moving Averages:
|
MA(5): 2.69  MA(20): 2.57
MA(100): 2.79 MA(250): 2.61
|
|
MACD:
|
MACD(12,26):
Signal(12,26,9): -0.02
|
|
%K %D:
|
%K(14,3): 71.98 %D(3): 73.92
|
|
RSI:
|
RSI(14): 53.76
|
|
52-Week:
|
High:
Low: Change(%): 80.0
|
|
Average Vol(K):
|
3-Month: 84900
10-Days 30912
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.BIOS has closed below upper band by 25.7%. Bollinger Bands are 34% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-03-26T07:07:13-04:00
BioScrip timely files Annual Form 10-K, provides update on financial statement corrections
2018-03-20T15:09:00-04:00
Lifshitz & Miller LLP Announces Investigation of BioScrip, Inc., Civitas Solutions, Inc., Iridex Corp., OHR Pharmaceutical, Inc., Overstock.com, Inc., Syneos Health, Inc., Ubiquiti Networks, Inc. and WageWorks, Inc.
2018-03-15T17:30:00-04:00
BioScrip Provides Update on Annual Form 10-K Filing Status
2018-03-14T13:37:00-04:00
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of BioScrip, Inc. -- BIOS
2018-03-09T14:30:00-05:00
Glancy Prongay & Murray LLP Announces Investigation on Behalf of BioScrip, Inc. Investors
2018-03-08T20:11:06-05:00
BioScrip, Inc's (BIOS) CEO Daniel Greenleaf on Q4 2017 Results - Earnings Call Transcript
2018-03-08T18:27:00-05:00
Milberg Tadler Phillips Grossman LLP Announces Investigation of BioScrip, Inc.
2018-03-08T17:15:00-05:00
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of BioScrip, Inc.
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
